Frequent detection of human adenovirus from the lower gastrointestinal tract in men who have sex with men

PLoS ONE

Volumn 5, Issue 6, 2010, Pages

  Curlin, Marcel E ^a,b   Huang, Meei Li ^b   Lu, Xiaoyan ^e   Celum, Connie L ^b   Sanchez, Jorge ^c   Selke, Stacy ^b   Baeten, Jared M ^b   Zuckerman, Richard A ^d   Erdman, Dean D ^e   Corey, Lawrence ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c ASOCIACIÓN CIVIL IMPACTA SALUD Y EDUCACIÓN   (Peru)

^d DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; HOMOSEXUALITY; HUMAN; HUMAN ADENOVIRUS; HUMAN ADENOVIRUS 26; HUMAN ADENOVIRUS 35; HUMAN ADENOVIRUS 48; HUMAN ADENOVIRUS 5; HUMAN ADENOVIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 1; INTESTINE; LATENT VIRUS INFECTION; MALE; NONHUMAN; RECTUM SWAB; RETROSPECTIVE STUDY; SMEAR; VIRUS DETECTION; VIRUS LOAD; VIRUS REACTIVATION; VIRUS SHEDDING; VIRUS TITRATION; ADENOVIRUS; GENETICS; ISOLATION AND PURIFICATION; POLYMERASE CHAIN REACTION; RECTUM; SERODIAGNOSIS; VIROLOGY;

ADENOVIRIDAE; HUMAN ADENOVIRUS; HUMAN ADENOVIRUS TYPE 5; HUMAN HERPESVIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS 1;

ADENOVIRIDAE; ADULT; COHORT STUDIES; DNA, VIRAL; HOMOSEXUALITY, MALE; HUMANS; MALE; NEUTRALIZATION TESTS; POLYMERASE CHAIN REACTION; RECTUM; VIRUS SHEDDING;

EID: 77956197488     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011321     Document Type: Article

References (52)

1. Echavarria M (2008) Adenoviruses in immunocompromised hosts. Clin Microbiol Rev 21: 704-715.
2. Hierholzer JC (1992) Adenoviruses in the immunocompromised host. Clin Microbiol Rev 5: 262-274.
3. Cunningham AL, Grohman GS, Harkness J, Law C, Marriott D, et al. (1988) Gastrointestinal viral infections in homosexual men who were symptomatic and seropositive for human immunodeficiency virus. J Infect Dis 158: 386-391.
4. Buimovici-Klein E, Lange M, Ong KR, Grieco MH, Cooper LZ (1988) Virus isolation and immune studies in a cohort of homosexual men. J Med Virol 25: 371-385.
5. Durepaire N, Ranger-Rogez S, Gandji JA, Weinbreck P, Rogez JP, et al. (1995) Enteric prevalence of adenovirus in human immunodeficiency virus seropositive patients. J Med Virol 45: 56-60.
6. Cinek O, Witso E, Jeansson S, Rasmussen T, Drevinek P, et al. (2006) Longitudinal observation of enterovirus and adenovirus in stool samples from Norwegian infants with the highest genetic risk of type 1 diabetes. J Clin Virol 35: 33-40.
7. (1993) Intestinal malabsorption of HIV-infected children: relationship to diarrhoea, failure to thrive, enteric micro-organisms and immune impairment. The Italian Paediatric Intestinal/HIV Study Group. AIDS 7: 1435-1440.
8. Lew JF, Moe CL, Monroe SS, Allen JR, Harrison BM, et al. (1991) Astrovirus and adenovirus associated with diarrhea in children in day care settings. J Infect Dis 164: 673-678.
9. Hillis WD, Cooper MR, Bang FB (1973) Adenovirus infections in West Bengal. I. Persistence of viruses in infants and young children. Indian J Med Res 61: 980-988.
10. Kaljot KT, Ling JP, Gold JW, Laughon BE, Bartlett JG, et al. (1989) Prevalence of acute enteric viral pathogens in acquired immunodeficiency syndrome patients with diarrhea. Gastroenterology 97: 1031-1032.
11. Khoo SH, Bailey AS, de Jong JC, Mandal BK (1995) Adenovirus infections in human immunodeficiency virus-positive patients: clinical features and molecular epidemiology. J Infect Dis 172: 629-637.
12. Gonzalez GG, Pujol FH, Liprandi F, Deibis L, Ludert JE (1998) Prevalence of enteric viruses in human immunodeficiency virus seropositive patients in Venezuela. J Med Virol 55: 288-292.
13. Grohmann GS, Glass RI, Pereira HG, Monroe SS, Hightower AW, et al. (1993) Enteric viruses and diarrhea in HIV-infected patients. Enteric Opportunistic Infections Working Group. N Engl J Med 329: 14-20.
14. Schmidt W, Schneider T, Heise W, Weinke T, pple HJ, et al. (1996) Stool viruses, coinfections, and diarrhea in HIV-infected patients. Berlin Diarrhea/ Wasting Syndrome Study Group. J Acquir Immune Defic Syndr Hum Retrovirol 13: 33-38.
15. Buchbinder SP, Mehrotra DV, Duerr A, Fitzgerald DW, Mogg R, et al. (2008) Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 372: 1881-1893.
16. Rodriguez A, Goudsmit J, Companjen A, Mintardjo R, Gillissen G, et al. (2008) Impact of recombinant adenovirus serotype 35 priming versus boosting of a Plasmodium falciparum protein: characterization of T- and B-cell responses to liver-stage antigen 1. Infect Immun 76: 1709-1718.
17. Hoelscher MA, Garg S, Bangari DS, Belser JA, Lu X, et al. (2006) Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice. Lancet 367: 475-481.
18. Wang J, Thorson L, Stokes RW, Santosuosso M, Huygen K, et al. (2004) Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis. J Immunol 173: 6357-6365.
19. Sullivan NJ, Sanchez A, Rollin PE, Yang ZY, Nabel GJ (2000) Development of a preventive vaccine for Ebola virus infection in primates. Nature 408: 605-609.
20. Robb ML (2008) Failure of the Merck HIV vaccine: an uncertain step forward. Lancet 372: 1857-1858.
21. Perreau M, Pantaleo G, Kremer EJ (2008) Activation of a dendritic cell-T cell axis by Ad5 immune complexes creates an improved environment for replication of HIV in T cells. J Exp Med 205: 2717-2725.
22. Leen AM, Sili U, Vanin EF, Jewell AM, Xie W, et al. (2004) Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD8+ T cells. Blood 104: 2432-2440.
23. Lemckert AA, Sumida SM, Holterman L, Vogels R, Truitt DM, et al. (2005) Immunogenicity of heterologous prime-boost regimens involving recombinant adenovirus serotype 11 (Ad11) and Ad35 vaccine vectors in the presence of antiad5 immunity. J Virol 79: 9694-9701.
24. Vogels R, Zuijdgeest D, van Rijnsoever R, Hartkoorn E, Damen I, et al. (2003) Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity. J Virol 77: 8263-8271.
25. Radosevic K, Wieland CW, Rodriguez A, Weverling GJ, Mintardjo R, et al. (2007) Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon. Infect Immun 75: 4105-4115.
26. Baden L, Dolin R, O'Brien K, Abbink P, La Porte A, et al. (2009) OA05-06 LB. First-in-human Phase 1 safety and immunigenicity of an adenovirus serotype 26 HIV-1 vaccine vector. Retrovirology 6: O36.
27. Zuckerman RA, Lucchetti A, Whittington WL, Sanchez J, Coombs RW, et al. (2007) Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial. J Infect Dis 196: 1500-1508.
28. Kurosaki K, Miwa N, Yoshida Y, Kurokawa M, Kurimoto M, et al. (2004) Therapeutic basis of vidarabine on adenovirus-induced haemorrhagic cystitis. Antivir Chem Chemother 15: 281-285.
29. Naesens L, Lenaerts L, Andrei G, Snoeck R, Van Beers D, et al. (2005) Antiadenovirus activities of several classes of nucleoside and nucleotide analogues. Antimicrob Agents Chemother 49: 1010-1016.
30. Huang ML, Nguy L, Ferrenberg J, Boeckh M, Cent A, et al. (2008) Development of multiplexed real-time quantitative polymerase chain reaction assay for detecting human adenoviruses. Diagn Microbiol Infect Dis 62: 263-271.
31. Gray GC, McCarthy T, Lebeck MG, Schnurr DP, Russell KL, et al. (2007) Genotype prevalence and risk factors for severe clinical adenovirus infection, United States 2004-2006. Clin Infect Dis 45: 1120-1131.
32. Lu X, Erdman DD (2006) Molecular typing of human adenoviruses by PCR and sequencing of a partial region of the hexon gene. Arch Virol 151: 1587-1602.
33. Hall T (1999) Bioedit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symposium series. pp 95-98.
34. Tamura K, Dudley J, Nei M, Kumar S (2007) MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24: 1596-1599.
35. Ebner K, Pinsker W, Lion T (2005) Comparative sequence analysis of the hexon gene in the entire spectrum of human adenovirus serotypes: phylogenetic, taxonomic, and clinical implications. J Virol 79: 12635-12642.
36. Hierholzer JC, Bingham PG (1978) Vero microcultures for adenovirus neutralization tests. J Clin Microbiol 7: 499-506.
37. Laughon BE, Druckman DA, Vernon A, Quinn TC, Polk BF, et al. (1988) Prevalence of enteric pathogens in homosexual men with and without acquired immunodeficiency syndrome. Gastroenterology 94: 984-993.
38. Saulsbury FT, Winkelstein JA, Yolken RH (1980) Chronic rotavirus infection in immunodeficiency. J Pediatr 97: 61-65.
39. Gray JR, Rabeneck L (1989) Atypical mycobacterial infection of the gastrointestinal tract in AIDS patients. Am J Gastroenterol 84: 1521-1524.
40. Thea DM, Glass R, Grohmann GS, Perriens J, Ngoy B, et al. (1993) Prevalence of enteric viruses among hospital patients with AIDS in Kinshasa, Zaire. Trans R Soc Trop Med Hyg 87: 263-266.
41. Rodriguez-Baez N, O'Brien R, Qiu SQ, Bass DM (2002) Astrovirus, adenovirus, and rotavirus in hospitalized children: prevalence and association with gastroenteritis. J Pediatr Gastroenterol Nutr 35: 64-68.
42. Thomas PD, Pollok RC, Gazzard BG (1999) Enteric viral infections as a cause of diarrhoea in the acquired immunodeficiency syndrome. HIV Med 1: 19-24.
43. Albrecht H, Stellbrink HJ, Fenske S, Ermer M, Raedler A, et al. (1993) Rotavirus antigen detection in patients with HIV infection and diarrhea. Scand J Gastroenterol 28: 307-310.
44. Horwitz MS, Valderrama G, Hatcher V, Korn R, deJong P, et al. (1984) Characterization of adenovirus isolates from AIDS patients. Ann N Y Acad Sci 437: 161-174.
45. Evans AS (1958) Latent adenovirus infections of the human respiratory tract. Am J Hyg 67: 256-266.
46. Horvath J, Palkonyay L, Weber J (1986) Group C adenovirus DNA sequences in human lymphoid cells. J Virol 59: 189-192.
47. Kaye SB, Lloyd M, Williams H, Yuen C, Scott JA, et al. (2005) Evidence for persistence of adenovirus in the tear film a decade following conjunctivitis. J Med Virol 77: 227-231.
48. Hierholzer JC, Wigand R, Anderson LJ, Adrian T, Gold JW (1988) Adenoviruses from patients with AIDS: a plethora of serotypes and a description of five new serotypes of subgenus D (types 43-47). J Infect Dis 158: 804-813.
49. Abbink P, Lemckert AA, Ewald BA, Lynch DM, Denholtz M, et al. (2007) Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D. J Virol 81: 4654-4663.
50. Thorner AR, Vogels R, Kaspers J, Weverling GJ, Holterman L, et al. (2006) Age dependence of adenovirus-specific neutralizing antibody titers in individuals from sub-Saharan Africa. J Clin Microbiol 44: 3781-3783.
51. Mast TC, Kierstead L, Gupta SB, Nikas AA, Kallas EG, et al. (2009) International epidemiology of human pre-existing adenovirus (Ad) type-5, type- 6, type-26 and type-36 neutralizing antibodies: Correlates of high Ad5 titers and implications for potential HIV vaccine trials. Vaccine.
52. Roy S, Vandenberghe LH, Kryazhimskiy S, Grant R, Calcedo R, et al. (2009) Isolation and characterization of adenoviruses persistently shed from the gastrointestinal tract of non-human primates. PLoS Pathog 5: e1000503.